Nuveen, LLC Amphastar Pharmaceuticals, Inc. Call Options Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AMPH
# of Institutions
264Shares Held
33.9MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$149 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$60.9 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$55.6 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$40.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$34.1 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.23B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...